AI Article Synopsis

  • Heterozygous germline variants are linked to about 5% of Lynch syndrome (LS) cases, but their true prevalence may be underestimated due to challenges in routine screening caused by similar pseudogenes.
  • The study identified 200 heterozygous variants in 195 French patients, with notable findings that a specific variant, c.137G>T, appears in 18% of cases, but no clear founder effect was established.
  • Results indicate that while many variant carriers do not fit traditional family history criteria for LS, they still face a significant risk of early-onset cancers, particularly colorectal and endometrial types, underscoring the need for deeper understanding of variant penetrance.*

Article Abstract

Background: Heterozygous germline variants are responsible for about 5% of Lynch syndrome (LS) but their prevalence is most likely underestimated because of complicated routine screening caused by highly homologous pseudogenes. Consequently, there is limited knowledge on the implication of the gene in LS.

Methods: We report 200 heterozygous variants identified in 195 French patients, including 112 unique variants classified as class-3/4/5.

Results: Genomic rearrangements account for 18% of alterations. The c.137G>T variant was observed in 18% of the patients, but a founder effect could not be clearly identified by haplotype analysis. Among class-4/5 variant carriers, the median age at first tumour onset was 49 years with a predominance of colorectal (80%) and endometrial (8.1%) cancers. Seven patients developed colorectal cancers before the age of 30 with the youngest at the age of 21. Only 6.2% of class-4/5 carriers had a family history fulfilling Amsterdam I/II criteria among patients with available data. Tumours from variant carriers exhibited microsatellite instability (96%) and loss of PMS2 expression (76%), confirming the high predictive value of somatic analysis.

Conclusion: Our results provide further insight into the role of the gene in LS. While variants are mostly detected in families not fulfilling Amsterdam criteria, which supports their lower penetrance, they can nevertheless cause early-onset cancers, highlighting the variability of their penetrance.

Download full-text PDF

Source
http://dx.doi.org/10.1136/jmedgenet-2019-106256DOI Listing

Publication Analysis

Top Keywords

heterozygous variants
8
french patients
8
lynch syndrome
8
variant carriers
8
fulfilling amsterdam
8
variants
5
patients
5
characterisation heterozygous
4
variants french
4
patients lynch
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!